Carera Pharma A/S: Financial statements 2022
CVR: 39913046
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Carera Pharma A/S (CVR 39913046) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -317,584 and a net result of DKK -2,026,210 compared with DKK -607,433 the year before. Equity in the 2022 report amounted to DKK -2,679,605. The company had 7 employees in the financial year.
- Gross Profit
- DKK -317,584
- Profit/Loss
- DKK -2,026,210
- Equity
- DKK -2,679,605
- Total Assets
- DKK 1,125,505
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -318K | -2M | -2.7M | 7 |
| 2021 | - | 1.8M | -607K | -653K | 7 |
| 2020 | - | 2.6M | -278K | -46K | 10 |
Official annual report
Keep an eye on Carera Pharma A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Carera Pharma A/S has published its annual report for 2021. Gross profit came to DKK 1,768,836, and the net result was DKK -607,433.
About Carera Pharma A/S
Carera Pharma A/S is a Danish company of the type Aktieselskab based in København S, founded in 2018. The company is registered under the industry Engroshandel med andre fødevarer. The company was previously named Yokoso A/S. The management consists of Zengwen Jia. The board consists of Chenglin Gu (chair), Chen Liu and Zengwen Jia. The company is owned by Zengwen Jia. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -417,453 and a net result of DKK -626,216 compared with DKK -500,690 the year before. Equity in the 2025 report amounted to DKK -4,218,297.